(Q36684362)

15 August 2017

1 reference

title

Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention (English)

1 reference

15 August 2017

1 reference

3

Robert Silverman

1 reference

15 August 2017

Eric A Klein

1

1 reference

PubMed ID

17169635

15 August 2017

Graham Casey

series ordinal

2

1 reference

PubMed ID

17169635

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

68

1 reference

15 August 2017

6

1 reference

15 August 2017

1145-1151

1 reference

Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Cancer in twins: genetic and nongenetic familial risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

A candidate prostate cancer susceptibility gene at chromosome 17p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Mutations in CHEK2 associated with prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Evidence for a prostate cancer susceptibility locus on the X chromosome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Implications for RNase L in prostate cancer biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

The Toll-IL-1 receptor adaptor family grows to five members.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Epidemiology of inflammation and prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Meta-analysis of measures of sexual activity and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Epidemiologic association between prostatitis and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

The influence of finasteride on the development of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.08.1074

10.1016/J.UROLOGY.2006.08.1074

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17169635